| Biological Sciences | Lifetime | 441 | GB 38 | 99.95 |
| Medical and Health Sciences | Lifetime | 822 | GB 94 | 99.96 |
| Medical Physiology | Lifetime | 12 | GB 1 | 99.98 |
| Neuroscience of Neurology | Lifetime | 47 | GB 5 | 99.63 |
| Clinical Neurology | Lifetime | 76 | GB 15 | 99.74 |
| Molecular Biology | Lifetime | 505 | GB 32 | 99.75 |
| Genetics | Lifetime | 268 | GB 29 | 99.38 |
| Cellular and Molecular Neuroscience | Lifetime | 279 | GB 30 | 99.00 |
| Clinical Pharmacology | Lifetime | 913 | GB 87 | 95.67 |
| History of Philosophy | Lifetime | 876 | GB 122 | 91.22 |
| Biochemistry | Lifetime | 938 | GB 65 | 77.27 |
| Clinical Biochemistry | Lifetime | 879 | GB 81 | 70.12 |
| Medical Physiology | 2021-2025 | 27 | GB 4 | 99.63 |
| Neuroscience of Neurology | 2021-2025 | 113 | GB 7 | 94.29 |
| Genetics | 2021-2025 | 409 | GB 52 | 88.97 |
| Clinical Neurology | 2021-2025 | 360 | GB 39 | 88.73 |
| Nuclear Receptors and Signaling | Lifetime | 1 | GB 1 | 99.93 |
| Alzheimer's disease research and treatments | Lifetime | 13 | GB 1 | 99.98 |
| Bioinformatics and Genomic Networks | Lifetime | 6 | GB 1 | 99.83 |
| Neurological diseases and metabolism | Lifetime | 3 | GB 1 | 99.94 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 10 | GB 1 | 99.81 |
| Computational Drug Discovery Methods | Lifetime | 37 | GB 2 | 99.56 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 31 | GB 5 | 99.85 |
| Prion Diseases and Protein Misfolding | Lifetime | 8 | GB 3 | 99.78 |
| Genomics and Rare Diseases | Lifetime | 49 | GB 6 | 99.40 |
| Genetic Associations and Epidemiology | Lifetime | 67 | GB 20 | 99.45 |
| Biological Research and Disease Studies | Lifetime | 1 | GB 1 | 97.58 |
| Genetic Neurodegenerative Diseases | Lifetime | 80 | GB 18 | 99.30 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 55 | GB 6 | 99.05 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 150 | GB 21 | 98.99 |
| Hermeneutics and Narrative Identity | Lifetime | 113 | GB 24 | 95.95 |
| RNA regulation and disease | Lifetime | 119 | GB 10 | 98.56 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 262 | GB 19 | 98.99 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 76 | GB 8 | 98.88 |
| Dementia and Cognitive Impairment Research | Lifetime | 246 | GB 29 | 99.21 |
| Lysosomal Storage Disorders Research | Lifetime | 114 | GB 15 | 98.25 |
| Health, Medicine and Society | Lifetime | 505 | GB 29 | 94.48 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 460 | GB 51 | 98.03 |
| Mitochondrial Function and Pathology | Lifetime | 896 | GB 81 | 97.65 |
| Aging, Elder Care, and Social Issues | Lifetime | 474 | GB 60 | 93.62 |
| Inflammation biomarkers and pathways | Lifetime | 48 | GB 2 | 96.59 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 307 | GB 38 | 97.08 |
| Genomic variations and chromosomal abnormalities | Lifetime | 555 | GB 64 | 96.55 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 499 | GB 41 | 95.34 |
| Cerebrovascular and genetic disorders | Lifetime | 145 | GB 22 | 94.27 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 931 | GB 68 | 93.37 |
| GDF15 and Related Biomarkers | Lifetime | 216 | GB 14 | 89.98 |
| Hereditary Neurological Disorders | Lifetime | 644 | GB 61 | 91.58 |
| Biochemical Acid Research Studies | Lifetime | 933 | GB 80 | 85.81 |
| Down syndrome and intellectual disability research | Lifetime | 459 | GB 97 | 86.07 |
| 14-3-3 protein interactions | Lifetime | 850 | GB 49 | 77.87 |
| Alzheimer's disease research and treatments | 2021-2025 | 31 | GB 1 | 99.66 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 29 | GB 1 | 97.00 |
| Neurological diseases and metabolism | 2021-2025 | 16 | GB 4 | 97.50 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 171 | GB 16 | 97.62 |
| Genetic Associations and Epidemiology | 2021-2025 | 199 | GB 42 | 95.67 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 376 | GB 18 | 93.94 |
| Bioinformatics and Genomic Networks | 2021-2025 | 197 | GB 10 | 91.47 |
| Lysosomal Storage Disorders Research | 2021-2025 | 205 | GB 20 | 90.37 |
| Nuclear Receptors and Signaling | 2021-2025 | 101 | GB 9 | 84.83 |
| RNA regulation and disease | 2021-2025 | 338 | GB 22 | 82.15 |
| Inflammation biomarkers and pathways | 2021-2025 | 54 | GB 3 | 80.27 |